Mark Shlapobersky

Innovative Ph.D. scientist with a track record of guiding teams in in vivo and in vitro research projects yielding breakthrough insights across multiple disciplines: Oncology, Virology, Molecular and Cellular Biology, Immunology and Vaccinology.

• Extensive experience in preclinical development, including Patient Derived Xenograft (PDX) tumor models
• In-depth understanding of infectious diseases, including assay development and utilizing diverse immunology, cell and molecular biology techniques
• Extensive expertise in vaccine development, cell and molecular biology
Excellent written and verbal skills, with a strong publication record

Core Competencies:
Research Project Planning and Implementation, Patient Derived Xenografts (PDX), Next Generation Sequencing (NGS), Molecular Biology, Virology Assays, Biomarker Characterization, Experimental Design and Data Analysis, Immunology assays, Product Development, and Team Leadership and Training.